Literature DB >> 7433912

Effect of four dopamine receptor antagonists on gastrin secretion in healthy subjects.

R Caldara, C Ferrari, C Barbieri, M Romussi.   

Abstract

The effect of 1 week of oral treatment with four antidopaminergic drugs--metoclopramide, sulpiride, haloperidol, and pimozide--on fasting and meal-stimulated serum gastrin levels has been evaluated in healthy subjects. All of the four drugs significantly reduced the gastrin response to a meal, whereas basal concentration was unaffected. It is suggested that this action is mediated by central nervous system dopamine receptor blockade, which might act either via nervous or humoral mechanisms to inhibit gastrin release.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7433912     DOI: 10.3109/00365528009181504

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Lack of effect of domperidone on gastrin release: evidence for a peripheral activity of the drug.

Authors:  E Masci; R Caldara; P A Testoni; M Guslandi; M Cambielli; S Passaretti; A Tittobello
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

2.  Dopaminergic control of gastric acid and gastrin secretion in man: lack of effects after acute oral administration of ibopamine, an analogue of dopamine.

Authors:  R Caldara; E Masci; C Barbieri; M Cambielli; C Ferrari; A Tittobello
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

Review 3.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine.

Authors:  M Goiny; K Uvnäs-Moberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

5.  Effect of sulpiride isomers on gastric acid and gastrin secretion in healthy man.

Authors:  R Caldara; E Masci; M Cambielli; A Tittobello; V Piepoli; C Barbieri
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.